Imco Sibum

Mr. Imco Sibum

University of Groningen
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
ISImco Sibum
Imco Sibum
PHPaul Hagedoorn
Paul Hagedoorn
ABAnne Haaije de Boer
Anne Haaije de Boer
HFHenderik Frijlink
Henderik Frijlink
FGFloris Grasmeijer
Floris Grasmeijer
In recent years there is an increasing interest in the pulmonary delivery of large cohesive powder doses, i.e. drugs with a low potency such as antibiotics or drugs with a high potency that need a substantial fraction of excipient(s) such as vaccines stabilized in sugar glasses. The pulmonary delivery of high powder doses comes with unique challenges. For low potency drugs, the use of excipients should be minimized to limit the powder mass to be inhaled as much as possible. To achieve this objective the inhaler design should be adapted to the properties of the API in order to achieve a compatible combination of the drug formulation and inhaler device. The inhaler should have an appropriate powder dosing principle for which prefilled compartments seem most appropriate. The drug formulation should not only allow for accurate filling of these compartments but also enable efficient compartment emptying during inhalation. The dispersion principle must have the capacity to disperse considerable amounts of powder in a short time frame that allows the powder to reach the deep lung. Last, but not least, the inhaler should be simple and intuitive in use, be cost-effective and exhibit accurate and consistent, preferably patient independent, pulmonary delivery performance.

25 December 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ISImco Sibum
Imco Sibum
PHPaul Hagedoorn
Paul Hagedoorn
MKMarkus P. G. Kluitman
Markus P. G. Kluitman
MKMartijn Kloezen
Martijn Kloezen
HFHenderik Frijlink
Henderik Frijlink
FGFloris Grasmeijer
Floris Grasmeijer
Tuberculosis is the leading cause of death from a single infectious pathogen worldwide. Lately, the targeted delivery of antibiotics to the lungs via inhalation has received increasing interest. In a previous article, we reported on the development of a spray-dried dry powder isoniazid formulation containing an L-leucine coating. It dispersed well but had poor physical stability. In this study, we aimed to improve the stability by improving the leucine coating. To this end, we optimized the spray-drying conditions, the excipient content, and the excipient itself. Using L-leucine, the tested excipient contents (up to 5%) did not result in a stable powder. Contrary to L-leucine, the stability attained with trileucine was satisfactory. Even when exposed to 75% relative humidity, the formulation was stable for at least three months. The optimal formulation contained 3% trileucine w/w. This formulation resulted in a maximum fine particle dose of 58.00 ± 2.56 mg when a nominal dose of 80 mg was dispersed from the Cyclops® dry powder inhaler. The improved moisture protection and dispersibility obtained with trileucine are explained by its amorphous nature and a higher surface enrichment during drying. Dispersion efficiency of the device decreases at higher nominal doses.

13 May 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ISImco Sibum
Imco Sibum
PHPaul Hagedoorn
Paul Hagedoorn
HFHenderik Frijlink
Henderik Frijlink
FGFloris Grasmeijer
Floris Grasmeijer
Tuberculosis is a major health problem and remains one of the main causes of mortality. In recent years, there has been an increased interest in the pulmonary delivery of antibiotics to treat tuberculosis. Isoniazid is one of these antibiotics. In this study, we aimed to characterize isoniazid and formulate it into a dry powder for pulmonary administration with little or no excipient, and for use in the disposable Twincer® inhaler. Isoniazid was jet milled and spray dried with and without the excipient l-leucine. Physiochemical characterization showed that isoniazid has a low Tg of −3.99 ± 0.18 °C and starts to sublimate around 80 °C. Milling isoniazid with and without excipients did not result in a suitable formulation, as it resulted in a low and highly variable fine particle fraction. Spray drying pure isoniazid resulted in particles too large for pulmonary administration. The addition of 5% l-leucine resulted in a fraction <5 µm = 89.61% ± 1.77% from spray drying, which dispersed well from the Twincer®. However, storage stability was poor at higher relative humidity, which likely results from dissolution-crystallization. Therefore, follow up research is needed to further optimize this spray dried formulation.

9 July 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ISImco Sibum
Imco Sibum
PHPaul Hagedoorn
Paul Hagedoorn
CBCarel Botterman
Carel Botterman
HFHenderik Frijlink
Henderik Frijlink
FGFloris Grasmeijer
Floris Grasmeijer
In recent years there has been increasing interest in the pulmonary delivery of high dose dry powder drugs, such as antibiotics. Drugs in this class need to be dosed in doses far over 2.5 mg, and the use of excipients should therefore be minimized. To our knowledge, the effect of the automatic filling of high dose drug formulations on the maximum dose that can be filled in powder inhalers, and on the dispersion behavior of the powder, have not been described so far. In this study, we aimed to investigate these effects after filling with an Omnidose, a vacuum drum filler. Furthermore, the precision and accuracy of the filling process were investigated. Two formulations were used—an isoniazid formulation we reported previously and an amikacin formulation. Both formulations could be precisely and accurately dosed in a vacuum pressure range of 200 to 600 mbar. No change in dispersion was seen after automatic filling. Retention was decreased, with an optimum vacuum pressure range found from 400 to 600 mbar. The nominal dose for amikacin was 57 mg, which resulted in a fine particle dose of 47.26 ± 1.72 mg. The nominal dose for isoniazid could be increased to 150 mg, resulting in a fine particle dose of 107.35 ± 13.52 mg. These findings may contribute to the understanding of the upscaling of high dose dry powder inhalation products.

16 October 2025 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Open access
PHPatrick He
Patrick He
ISImco Sibum
Imco Sibum
WNWietze Nijdam
Wietze Nijdam
NBNicolas Buchmann
Nicolas Buchmann
JSJulio Soria
Julio Soria
DTDaniela Traini
Daniela Traini

1 June 2026 in Physics of Fluids
Verified
Journal Article
Open access
AHAlireza Heidarian
Alireza Heidarian
ISImco Sibum
Imco Sibum
WNWietze Nijdam
Wietze Nijdam
NBNicolas Buchmann
Nicolas Buchmann
DTDaniela Traini
Daniela Traini
JSJulio Soria
Julio Soria
Controlled droplet formation is essential in many industrial processes, where flow instabilities govern droplet size and uniformity. In this study, the effects of acoustic forcing on jets and droplets formed from micronozzles were investigated to quantify how external acoustic perturbations interact with the Rayleigh–Plateau instability. Acoustic forcing was applied using a lead zirconate titanate (PZT) ring actuator coupled to a nozzle assembly with interchangeable nozzles with diameters of 16, 32, and 64 μm. High-speed, high-spatial-resolution imaging was employed to characterize breakup length and frequency, as well as the downstream evolution of droplet size, velocity, and aspect ratio up to 200 nozzle diameters from the orifice. An open cylindrical cavity acting as a Helmholtz resonator enabled efficient acoustic coupling between the actuator and the jets. Experiments were conducted at fixed Reynolds (Re) and Weber (We) numbers to decouple viscous-inertial and inertial-capillary effects. Local probability density functions (PDFs) were evaluated to characterize the downstream evolution of droplet diameter, velocity, and aspect ratio. Acoustic forcing was found to shorten the breakup length and increase the breakup frequency while reducing the mean droplet size and aspect ratio across all nozzle geometries. Depending on nozzle diameter and operating condition, the response ranged from off-resonant enhancement of breakup to subharmonic synchronization and near 1:1 lock-in, with the clearest frequency matching observed for the 64 μm nozzle under the constant We condition. These results indicate strong coupling between the acoustic field and the liquid jet, leading to the formation of more uniform droplets across all nozzle geometries.